Glutathione disulfide
Also known as: GSH disulfide, GSSG, L-Glutathione oxidized, Oxidized glutathione
Source Glutathione disulfide at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Glutathione disulfide (GSSG) is the oxidized dimer of the tripeptide glutathione (GSH). It forms when two GSH molecules donate electrons to neutralise reactive species, creating a disulfide bond. In research settings GSSG is examined as a marker of cellular oxidative stress, a source of cysteine after reduction, and a component of the redox couple that influences ageing, neurodegeneration and cancer‑related ferroptosis.
Mechanism of Action
GSSG participates in the principal intracellular redox pair GSH/GSSG. When oxidative stress oxidises GSH, a disulfide bond links two molecules to generate GSSG. The enzyme glutathione reductase, using NADPH, reduces GSSG back to two GSH molecules, restoring antioxidant capacity. This cycle regulates the cellular redox potential, modulates signalling pathways, and supplies cysteine when GSSG is reduced intracellularly or extracellularly via the γ‑glutamyl cycle.
What the Research Shows
Reviews highlight that GSH levels decline with age, while higher GSH/GSSG ratios are associated with better healthspan. GSSG can serve as a systemic cysteine source, especially when reduced by glutathione reductase, but its precise role in ferroptosis remains uncertain, with animal studies showing that loss of GSH or its reductase does not automatically trigger ferroptotic death. Measurement of GSSG alongside GSH is technically challenging, and quantitative methods are still being refined. Observational data link altered GSSG dynamics to neurodegenerative diseases such as Parkinson's, yet most evidence is pre‑clinical or correlational.
Reported Benefits
Research suggests that the GSH/GSSG ratio may serve as a useful biomarker of oxidative stress and ageing, potentially indicating resilience to age‑related decline. Because GSSG can be reduced to replenish GSH, it may help maintain cellular redox balance in experimental models. Some studies propose that supporting GSSG reduction could assist cysteine availability in contexts where cystine uptake is limited.
Limitations of the Evidence
No human interventional trials have evaluated GSSG supplementation, so therapeutic claims are unsupported. The relationship between GSSG levels and ferroptosis is still debated, and animal models have not consistently demonstrated causality. Quantifying GSSG accurately remains difficult, limiting its reliability as a clinical marker. Overall, evidence is largely observational and mechanistic, lacking definitive efficacy data.
Safety Considerations
GSSG is an endogenous molecule studied primarily in vitro and in animal models; the abstracts do not report adverse events from experimental administration. Because safety data in humans are absent, potential risks, dosing thresholds, or contraindications are unknown. Researchers using intravenous, subcutaneous, or topical routes should monitor for unexpected immunogenic or oxidative reactions, acknowledging that safety has not been established for clinical use.
How It Is Administered
In research protocols GSSG has been delivered intravenously, subcutaneously, or applied topically, typically as a sterile aqueous solution. Formulations are prepared under laboratory conditions without standardized dosing regimens, reflecting its status as a investigational compound rather than an approved therapeutic.
Routes of Administration
Goals & Uses
- Redox status biomarkerResearch / DiagnosticsHigh
- Oxidative stress researchResearch ToolHigh
- Antioxidant system supportCellular ProtectionLow
- Protein glutathionylation modulationRedox SignalingModerate
- oxidative stress assessmentDiagnosticModerate
Contraindications
- Known hypersensitivity to glutathione compoundsAllergyHigh
- High systemic GSSG levels (severe oxidative stress)PathophysiologyModerate
Adverse Effects
- Injection site reactionsLocalUncommon
- NauseaGastrointestinalUncommonFeeling of sickness or urge to vomit
- Pro-oxidant effects at high concentrationsOxidative ToxicityUnknown
Drug Interactions
- Glutathione reductase inhibitorsModerate
- Cisplatin and platinum-based chemotherapeuticsModerate
Population Constraints
- PregnancyReproductive SafetyRelative
- Glucose-6-phosphate dehydrogenase (G6PD) deficiencyGenetic / MetabolicRelative
- NeonatesPediatricRelative
Regulatory Status
- European UnionUnapprovedNot EMA-approved; no marketing authorization for therapeutic use.
- United StatesUnapprovedNot an FDA‑approved drug
- United KingdomUnapprovedNot MHRA-approved as a medicinal product.
Not approved as a therapeutic agent; used as a biochemical marker of oxidative stress in research settings.
Evidence & Sources
- Glutathione and glutathione-dependent enzymes: From biochemistry to gerontology and successful agingJournal ArticleModerateLapenna D2023-01-01T00:00:00.000000Z
- Journal ArticleModerateArnér ESJ, Schmidt EE2024-01-01T00:00:00.000000Z
- Journal ArticleModerateJaeschke H, et al.2021-01-01T00:00:00.000000Z
- Journal ArticleModerateWu G, et al.2004-01-01T00:00:00.000000Z
- Journal ArticleModerateWinther JR, Thorpe C2014-01-01T00:00:00.000000Z
- Journal ArticleModerateSmeyne M, Smeyne RJ2013-01-01T00:00:00.000000Z
Frequently Asked Questions
What is the difference between glutathione and glutathione disulfide?
Glutathione (GSH) is the reduced, active thiol form that directly scavenges reactive species. When two GSH molecules are oxidised, they form a disulfide bond, creating glutathione disulfide (GSSG). Enzymatic reduction converts GSSG back to GSH, completing the redox cycle.
Can taking GSSG improve health or slow ageing?
Current evidence is limited to observational and mechanistic studies. Higher GSH/GSSG ratios correlate with better healthspan, but no clinical trials have shown that supplementing GSSG alone confers anti‑ageing benefits.
Is GSSG used to treat any disease?
No regulatory approvals exist for GSSG. It is investigated in laboratory settings for its role in oxidative stress, neurodegeneration, and cancer‑related ferroptosis, but therapeutic applications remain experimental.
How is GSSG measured in the laboratory?
Quantification typically involves thiol‑disulfide exchange assays and chromatographic techniques, but the abstracts note significant methodological challenges and a need for more reliable tools.
Are there safety concerns with experimental GSSG administration?
Safety data are sparse; the abstracts report no specific adverse effects in animal studies, but human safety has not been established, so caution is advised in any experimental use.
What is Glutathione disulfide used for?
Glutathione disulfide is educationally associated with: Redox status biomarker, Oxidative stress research, Antioxidant system support, Protein glutathionylation modulation, oxidative stress assessment. Educational only — not medical advice.
How is Glutathione disulfide administered?
Recorded routes of administration: Intravenous, Subcutaneous, Topical.
What are the potential side effects of Glutathione disulfide?
Reported adverse effects include: Injection site reactions, Nausea, Pro-oxidant effects at high concentrations. This list is not exhaustive — consult a qualified clinician.
Who should avoid Glutathione disulfide?
Recorded contraindications: Known hypersensitivity to glutathione compounds, High systemic GSSG levels (severe oxidative stress). Consult a qualified clinician before use.